FDA Approved: METHOTREXATE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for METHOTREXATE SODIUM from Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Gestational Trophoblastic Disease
• Juvenile Idiopathic Arthritis
• Non-hodgkin Lymphoma
• Osteosarcoma
• Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE SODIUM (METHOTREXATE SODIUM)

Snippet

SUPPL AP for METHOTREXATE (METHOTREXATE SODIUM)